Fluorescent biosensor for ultra-stability detection of Pax-5a based on a double cascade amplification strategy
- Chang Liu 1, Xinyi Zhang 1, Jun Xu 1, Min Gao 1, Suqin Wang 1, Hongbo Li 1
- Chang Liu 1, Xinyi Zhang 1, Jun Xu 1
- 1Key Laboratory of Energy Catalysis and Conversion of Nanchang, College of Chemistry and Materials, Jiangxi Normal University, Nanchang 330022, PR China.
- 0Key Laboratory of Energy Catalysis and Conversion of Nanchang, College of Chemistry and Materials, Jiangxi Normal University, Nanchang 330022, PR China.
|
December 22, 2024
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study introduces a novel dual amplification method for detecting the Pax-5a gene, crucial in B-lymphoblastic leukemia development. The biosensor offers high sensitivity and specificity for early clinical diagnosis.
Area Of Science
- Molecular Biology
- Biochemistry
- Genetics
Background
- Aberrant expression of Pax-5a is closely linked to the development of B-lymphoblastic leukemia.
- Accurate and sensitive detection of Pax-5a is vital for early diagnosis and treatment of this leukemia.
Purpose Of The Study
- To develop a novel, highly sensitive, and specific dual signal amplification strategy for detecting the Pax-5a gene.
- To combine Rolling Circle Amplification (RCA) and Entropy-driven Toehold-Mediated Strand Displacement (ETSD) for enhanced detection.
Main Methods
- A dual signal amplification strategy integrating RCA and ETSD was employed for Pax-5a detection.
- The method utilizes sequence-specific hybridization for high specificity.
- A fluorescent biosensor format was developed for signal readout.
Main Results
- The method achieved a reliable linear correlation for Pax-5a detection within a specific range.
- A low detection limit of 3.34 pM was obtained.
- Exceptional sensitivity was demonstrated, with recovery rates between 96.68-101.76% and a relative standard deviation of 5.47% in 1% human serum.
Conclusions
- The developed dual amplification biosensor provides a sensitive, specific, and stable method for Pax-5a detection.
- This novel approach offers a promising new tool for the early clinical diagnosis of acute lymphoblastic leukemia.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

